晚孕期母血浆D-二聚体对妊娠期高血压疾病的诊断价值

doi:10.3969/j.issn.1673-8640.2020.08.003

检验医学 ›› 2020, Vol. 35 ›› Issue (8): 753-756.DOI: 10.3969/j.issn.1673-8640.2020.08.003

晚孕期母血浆D-二聚体对妊娠期高血压疾病的诊断价值

陈益明¹(), 黄建霞², 施晓春³, 何佩², 沈涌海³

1.杭州市妇产科医院（杭州市妇幼保健院）产前筛查实验室,浙江杭州 310008
2.杭州市妇产科医院（杭州市妇幼保健院）产科,浙江杭州 310008
3.杭州市妇产科医院（杭州市妇幼保健院）检验科,浙江杭州 310008

收稿日期:2019-07-10 出版日期:2020-08-30 发布日期:2020-09-24
作者简介:null
作者简介：陈益明,男,1969年生,主任技师,主要从事产前筛查和产前诊断研究。
基金资助:
浙江省医药卫生科技计划项目（2018ZD036）;杭州市余杭区科技局科研项目（医疗卫生-2018008）

Diagnostic value of maternal plasma D-dimer and hypertensive disorders of pregnancy in late pregnancy

CHEN Yiming¹(), HUANG Jianxia², SHI Xiaochun³, HE Pei², SHEN Yonghai³

1. Department of Prenatal Screening Laboratory,Hangzhou Women's Hospital,Hangzhou Maternity and Child Health Care Hospital,Hangzhou 310008,Zhejiang,China
2. Department of Obstetrics,Hangzhou Women's Hospital,Hangzhou Maternity and Child Health Care Hospital,Hangzhou 310008,Zhejiang,China
3. Department of Clinical Laboratory,Hangzhou Women's Hospital,Hangzhou Maternity and Child Health Care Hospital,Hangzhou 310008,Zhejiang,China

Received:2019-07-10 Online:2020-08-30 Published:2020-09-24

摘要/Abstract

摘要：

目的评价妊娠第28~32周孕妇血浆D-二聚体（DD）水平对妊娠期高血压疾病（HDP）的诊断价值。方法收集2014年11月—2019年4月杭州市妇产科医院（杭州市妇幼保健院）产科住院分娩的2 299例孕妇资料,其中1 705例为正常孕妇（对照组）,299例孕妇患有妊娠高血压（GH）（GH组）,158例孕妇患有子痫前期（PE）（PE组）,137例孕妇患有重度子痫前期（SPE）（SPE组）。采用受试者工作特征（ROC）曲线来评价晚孕期母血浆DD水平对HDP的诊断价值。结果 GH组、PE组和SPE组的DD水平分别为1 730 μg/L、1 950 μg/L和2 030 μg/L,均高于对照组的1 520 μg/L,差异有统计学意义（P<0.001）,且有随病情进展逐渐升高的趋势。在对GH、PE、SPE的诊断价值方面,晚孕期母血浆DD的曲线下面积（AUC）分别为0.560（0.525~0.595,P=0.001）、0.614（0.567~0.660,P<0.001）、0.640（0.589~0.692,P<0.001）,当晚孕期母血浆DD的最佳临界值分别为1 325 μg/L、1 875 μg/L、1 795 μg/L时,对应的敏感性、特异性分别为0.746、0.389,0.544、0.652,0.635、0.624。结论晚孕期母血浆DD水平对HDP具有诊断价值。

关键词: 晚孕期, D-二聚体, 妊娠期高血压疾病, 诊断价值

Abstract:

Objective To investigate the diagnostic value of maternal plasma D-dimer（DD） and hypertensive disorders of pregnancy（HDP） in the 28-32 gestational weeks. Methods The data of 2 299 pregnant women who delivered in Hangzhou Women's Hospital（Hangzhou Maternity and Child Health Care Hospital） from November 2014 to April 2019 were collected. There were 299 gestational hypertension（GH） patients,158 preeclampsia（PE） patients and 137 severe preeclampsia（SPE） patients. A total of 1 705 healthy pregnant women were enrolled as control group. The performance of DD for HDP was evaluated by receiver operating characteristic（ROC） curve. Results In GH,PE and SPE groups,the levels of DD were 1 730,1 950 and 2 030 μg/L,respectively,which were higher than that in control group（1 520 μg/L,P<0.001）. With progress,the DD levels increased gradually. For the diagnosis of GH,PE and SPE,the areas under curves（AUC） of DD were 0.560（0.525-0.595,P=0.001）,0.614（0.567-0.660,P<0.001） and 0.640（0.589-0.692,P<0.001）,respectively. When the cut-off values of DD were 1 325,1 875 and 1 795 μg/L,the sensitivities were 0.746,0.544 and 0.635,and the specificities were 0.389,0.652 and 0.624,respectively. Conclusions The levels of DD in the late trimester of pregnancy play a predictive role to HDP.

Key words: Late pregnancy, D-dimer, hypertensive disorders of pregnancy, Diagnostic value

中图分类号:

R446.1

陈益明, 黄建霞, 施晓春, 何佩, 沈涌海. 晚孕期母血浆D-二聚体对妊娠期高血压疾病的诊断价值[J]. 检验医学, 2020, 35(8): 753-756.

CHEN Yiming, HUANG Jianxia, SHI Xiaochun, HE Pei, SHEN Yonghai. Diagnostic value of maternal plasma D-dimer and hypertensive disorders of pregnancy in late pregnancy[J]. Laboratory Medicine, 2020, 35(8): 753-756.

图/表 4

参考文献 16

[1]	ACOG practice bulletin No. 202:gestational hypertension and preeclampsia[J]. Obstet Gynecol,2019,133(1):e1-e25.
[2]	MAGEE L A,DADELSZEN P. State-of-the-art diagnosis and treatment of hypertension in pregnancy[J]. Mayo Clin Proc,2018,93(11):1664-1677.
[3]	MAGEE L A,SHARMA S,NATHAN H L,et al. The incidence of pregnancy hypertension in India,Pakistan,Mozambique,and Nigeria:a prospective population-level analysis[J]. PLoS Med,2019,16(4):e1002783.
[4]	BENSCHOP L,DUVEKOT J J,ROETERS VAN LENNEP J E. Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy[J]. Heart,2019,105(16):1273-1278.
[5]	KIM S J,AHN H J,PARK J Y,et al. The clinical significance of D-dimer concentrations in patients with gestational hypertensive disorders according to the severity[J]. Obstet Gynecol Sci,2017,60(6):542-548.
[6]	杨孜,张为远. 妊娠期高血压疾病诊治指南(2015)[J]. 中华妇产科杂志,2015,50(10):721-728.
[7]	HOFMEYR G J,BETRÁN A P,SINGATA-MADLIKI M,et al. Prepregnancy and early pregnancy calcium supplementation among women at high risk of preeclampsia:a multicentre,double-blind,randomised,placebo-controlled trial[J]. Lancet,2019,393(10169):330-339.
[8]	PINHEIRO M D B,JUNQUEIRA D R G,COELHO F F,et al. D-dimer in preeclampsia:systematic review and meta-analysis[J]. Clin Chim Acta,2012,414:166-170.
[9]	KUCUKGOI GULEC U,TUNCAY OZGUNEN F,BARIS GUZEL A,et al. An analysis of C-reactive protein,procalcitonin,and D-dimer in pre-eclamptic patients[J]. Am J Reprod Immunol,2012,68(4):331-337.
[10]	PORTELINHA A,CERDEIRA A S,BELO L,et al. Haemostatic factors in women with history of preeclampsia[J]. Thromb Res,2009,124(1):52-56.
[11]	OLADOSU-OLAYIWOLA O,OLAWUMI H,BABATUNDE A,et al. Fibrinolytic proteins of normal pregnancy and preeclamptic patients in North West Nigeria[J]. Afr Health Sci,2018,18(3):576-583.
[12]	BOZKURT M,YUMRU A E,SAHIN L,et al. Troponin I and D-dimer levels in preeclampsia and eclampsia:prospective study[J]. Clin Exp Obstet Gynecol,2015,42(1):26-31.
[13]	MANOLOV V,MARINOV B,MASSEVA A,et al. Plasma D-dimer levels in preeclampsia[J]. Akush Ginekol(Sofiia),2014,53(Suppl 2):15-18.
[14]	DUSSE L M,ALPOIM P N,LWALEED B A,et al. Is there a link between endothelial dysfunction,coagulation activation and nitric oxide synthesis in preeclampsia?[J]. Clin Chim Acta,2013,415:226-229.
[15]	XIONG Y,ZHOU S F,ZHOU R,et al. Alternations of maternal and cord plasma hemostasis in preeclampsia before and after delivery[J]. Hypertens Pregnancy,2011,30(3):347-358.
[16]	MARCQ G,BEAUGRAND DUBART L,TOURNOYS A,et al. Evaluation of D-dimer as a marker for severity in pregnancies with preeclampsia[J]. Gynecol Obstet Fertil,2014,42(6):393-398.

晚孕期母血浆D-二聚体对妊娠期高血压疾病的诊断价值

Diagnostic value of maternal plasma D-dimer and hypertensive disorders of pregnancy in late pregnancy

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表 4

参考文献 16

相关文章 15

编辑推荐

Metrics

[1]	顾玉, 梁晓艳, 马胜辉, 佟娜, 程明艳, 阎泽君. 血浆生物标志物在慢性肾脏病伴血栓栓塞患者中的表达及其近期预后评估价值[J]. 检验医学, 2023, 38(12): 1177-1182.
[2]	成景松, 阮家安, 孟建华. 血浆DD联合GRACE评分在老年急性心肌梗死预后评估中的价值[J]. 检验医学, 2022, 37(2): 162-164.
[3]	徐志刚, 卢霞, 龚晓霖. CA125、Fib、DD在卵巢癌化疗疗效评估中的价值[J]. 检验医学, 2022, 37(11): 1104-1105.
[4]	胡兵, 李改, 张会敏. 血清IL-6、DD水平在预测高血压患者脑出血风险中的作用[J]. 检验医学, 2022, 37(1): 63-67.
[5]	马成, 徐宏. NLR辅助诊断成人甲型流行性感冒的价值[J]. 检验医学, 2021, 36(7): 726-727.
[6]	刘婧, 王芳. 纤维蛋白相关标志物在重度急性胰腺炎预后评估中的价值[J]. 检验医学, 2021, 36(7): 766-767.
[7]	丁宁, 张卫峰, 陈小勇, 赵克温. 平均血小板体积、D-二聚体和纤维蛋白原降解产物与脑梗死及其病变程度的相关性研究[J]. 检验医学, 2021, 36(4): 384-387.
[8]	陈金来, 张菊英, 秦红, 赵津辉. 血清D-二聚体水平对预测老年慢性阻塞性肺疾病患者预后的价值[J]. 检验医学, 2021, 36(3): 309-312.
[9]	朱传新, 周玉平, 何艳, 周琴. NLR、CRP、PCT、DD、NT-proBNP在重症COVID-19中的诊断价值[J]. 检验医学, 2021, 36(2): 190-193.
[10]	郑如庚, 邸玉娜, 朱浩, 薛宏伟, 帖小佳, 赵合意, 马国驹. 脊柱外科手术后感染患者NLR、DD、PLR、IL-35、PCT、IL-10表达水平及预后分析[J]. 检验医学, 2021, 36(1): 92-94.
[11]	刘勤, 陈冲, 岳超. 提高D-二聚体的临界值对评估肺癌患者预后的价值[J]. 检验医学, 2020, 35(8): 763-766.
[12]	万文婷, 于波, 弓孟春, 史文钊, 郭昊, 杨杰. 循环肿瘤DNA对黑色素瘤诊断价值的Meta分析[J]. 检验医学, 2020, 35(8): 784-790.
[13]	王燕忠, 丁丽敏, 陈一瑞, 王永斌. miRNA-21-5p对食管癌的诊断价值及其与STAT3的相关性研究[J]. 检验医学, 2020, 35(6): 531-534.
[14]	王斌, 袁旭, 韩枫, 唐宁. 新型冠状病毒肺炎患者近期危重事件相关因素研究[J]. 检验医学, 2020, 35(6): 540-545.
[15]	陈星, 区静怡, 黄颖, 谭明凯, 陈嘉彬, 林路平, 梁志伟, 石亚玲. 多种血液学指标在新型冠状病毒肺炎中的诊断价值[J]. 检验医学, 2020, 35(4): 295-299.